Dapagliflozin & Sitagliptin Combination Emerges as Effective Strategy in T2DM Care
Written By : Dr Sunil Gupta
Published On 2026-05-04 06:00 GMT | Update On 2026-05-04 11:01 GMT
Advertisement
In this video, Dr Sunil Gupta, Diabetologist, CEO & MD, Sunil's Diabetes Care n' Research Centre Pvt. Ltd, Nagpur, discusses about the DIMETRIC study that provides a consensus-based evaluation of the dapagliflozin–sitagliptin combination for managing type 2 diabetes in India. Based on over 2,000 clinician-years of experience and a structured Likert-scale assessment, experts showed strong agreement across 16 clinical statements.
The combination demonstrated effective glycemic control along with notable cardiometabolic and renal benefits. Importantly, early initiation was widely recommended to overcome therapeutic inertia and improve long-term outcomes. Its dual-mechanism approach makes it a practical and evidence-driven option for diverse patient profiles in real-world settings.
As noted by Dr Sunil Gupta, this strategy supports more personalized and effective diabetes management in routine clinical practice.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.